Kodiak Sciences (KOD) Divestments (2022 - 2023)
Kodiak Sciences' (KOD) quarterly Divestments came in at -$314000.0 in Q4 2023, down 150.97% YoY from $616000.0 in Q4 2022, and down 150.97% on a QoQ basis from $616000.0 in Q4 2022.
Powered by 
Analysis
Kodiak Sciences (KOD) Divestments (2022 - 2023) Analysis & Trends
Kodiak Sciences (KOD) has 2 years of Divestments data on file, last reported at -$314000.0 in Q4 2023.
- Quarterly Divestments fell 150.97% year-over-year to -$314000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $302000.0 (changed N/A YoY) and the FY2022 annual result came in at $616000.0, changed N/A from the prior year.
- Divestments eased to -$314000.0 in Q4 2023, from $616000.0 in the prior quarter.
- In the past five years, Divestments ranged from a high of $616000.0 in Q4 2022 to a low of -$314000.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -314,000.00 |
| Dec 31, 2022 | 616,000.00 |